NEW YORK, Jan. 24 (GenomeWeb News) - Expanding its technologic product offering, Vitra Bioscience has made a nuclear translocation application available for its CellCard system for conducting highly multiplexed cell-based assays in high-content drug screening, the company said today.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.